Lost to follow-up
Lost to follow-up (LTFU) is a term used in clinical research and healthcare to describe a situation where a patient or study participant is no longer in contact with the healthcare provider or research team. This can occur for various reasons, including patient relocation, non-compliance, or death. LTFU is a significant issue as it can impact the validity and reliability of clinical trials and longitudinal studies.
Causes[edit | edit source]
There are several reasons why patients may become lost to follow-up:
- Relocation: Patients may move to a different geographic location and fail to inform their healthcare provider.
- Non-compliance: Patients may choose to discontinue their participation in a study or treatment regimen.
- Death: Patients may pass away, and the healthcare provider or research team may not be informed.
- Administrative errors: Miscommunication or errors in record-keeping can result in patients being lost to follow-up.
Impact on Research and Healthcare[edit | edit source]
Lost to follow-up can have significant implications for both clinical research and healthcare:
- Data integrity: Missing data from patients lost to follow-up can compromise the integrity of research findings.
- Bias: LTFU can introduce bias into study results, particularly if the reasons for loss to follow-up are related to the study outcomes.
- Healthcare outcomes: In clinical practice, LTFU can lead to poorer health outcomes for patients who do not receive continuous care.
Strategies to Minimize LTFU[edit | edit source]
Several strategies can be employed to minimize the occurrence of lost to follow-up:
- Patient tracking systems: Implementing robust tracking systems to monitor patient contact information and follow-up appointments.
- Patient engagement: Enhancing patient engagement through regular communication and support.
- Incentives: Providing incentives for patients to remain in contact and participate in follow-up activities.
- Data management: Ensuring accurate and up-to-date record-keeping to prevent administrative errors.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
